Please login to the form below

Not currently logged in
Email:
Password:

This Month

This page shows the latest This Month news and features for those working in and with pharma, biotech and healthcare.

FDA clears Sobi’s Gamifant for ‘hyper-inflammation’ disease

Earlier this month, Sobi agreed to acquire the US rights to AstraZeneca’s respiratory syncytial virus (RSV) prevention drug Synagis (palivizumab) in a deal worth $1.5bn. ... We would like to acknowledge the excellent work done by Novimmune to develop

Latest news

More from news
Approximately 19 fully matching, plus 617 partially matching documents found.

Latest Intelligence

  • 30 Women Leaders in UK Healthcare

    AstraZeneca UK in 2012 and serving as President of the ABPI since 2017.This month sees Lisa taking her 20-plus years of experience to a fresh new challenge, leaving ‘big ... As she wrote in a blog to mark International Women’s Day on 8 March this year

  • Digital health Digital health

    Companies that embrace this fast and hard will access better outcomes and improve population management.”. ... The solution, which combines tools based in cognitive behavioural theory, mindfulness, optimism and gratitude is firmly grounded in

  • Ten years at the forefront of patient experience Ten years at the forefront of patient experience

    Ten years at the forefront of patient experience. This month marks ten years of Hive, which has prompted us to reflect on how the world has changed over the last decade, ... in the future; the fact that the phrase ‘customer experience (CX) ’has

  • Deal Watch January 2018

    Three companies have been particularly active in deal making this month: Sanofi, Celgene and Takeda - more on this below. ... Celgene back in acquisition mode. While Sanofi led the way with a committed spend of $16.4bn in January, Celgene also had a

  • Pfizer and IBM's tech-enabled 'Parkinson’s house' Pfizer and IBM's tech-enabled 'Parkinson’s house'

    But this elegant home, surrounded by manicured lawns, is wired to beat the scourge of Parkinson’s disease. ... This is a turning point for Parkinson’s.”. The success of BlueSky is important for both companies.

More from intelligence
Approximately 0 fully matching, plus 102 partially matching documents found.

Latest appointments

  • BMS appoints CCO, Stephen Davies joins Eisai and more BMS appoints CCO, Stephen Davies joins Eisai and more

    Boerner takes over from Murdo Gordon (below), who jumped ship earlier this month to join Amgen as its executive vice president of global commercial operations. ... Prior to this, Davies served in various roles at Savient Pharmaceuticals and Boehringer

  • Dr Paula Salmikangas joins NDA Group Dr Paula Salmikangas joins NDA Group

    Dr Salmikangas is the second recent senior appointment at NDA Group following the appointment of Dr Van den Eynde, who joined earlier this month as its new vice president.

  • Maxor appoints new chief executive officer Maxor appoints new chief executive officer

    Maxor National Pharmacy Services has appointed Mike Ellis as its new chief executive officer, replacing John Ward who retired earlier this month. ... He established a strong culture at the Company and contributed meaningfully to Maxor's significant

  • Quantum Pharma promotes Chris Rigg to chief financial officer Quantum Pharma promotes Chris Rigg to chief financial officer

    Durham, UK-based Quantum Pharma has promoted Chris Rigg from group strategic director to chief financial officer and board member following the resignation of Martin Such earlier this month.

  • Dr Holger Adelmann joins DIA EMEA Dr Holger Adelmann joins DIA EMEA

    care community to this rapidly evolving region.”. ... Dr Adlemann succeeds Dr Jytte Lynvig who retired from the post earlier this month.

More from appointments
Approximately 0 fully matching, plus 17 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 14 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
EY Life Sciences

Our global reach Against a backdrop of regulatory, digital, financial and global transformation, Life Sciences companies are finding integration and...

Latest intelligence

A reflection of ESMO
Client Relationship Director Fabienne Wild from Ashfield Meetings & Events reflects on the recent conference season and on her experience at the European Society for Medical Oncology (ESMO)....
OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....

Infographics